Sitagliptin Phosphate + Metformin HCL
The combination of Sitagliptin Phosphate and Metformin HCL is widely used in the management of type 2 diabetes mellitus. Sitagliptin is a DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar by increasing insulin release and decreasing glucagon levels. Metformin is a biguanide that works by reducing hepatic glucose production and improving insulin sensitivity. Together, they provide effective glycemic control.